Market Overview

Endo Health Solutions to Buy Boca Pharmacal for $225M

Share:
Related ENDP
The Coming Drug-Patent Cliff Is Pushing This Portfolio Up
4 More Biotechs Leerink Is Looking At Post-Earnings
Tracking Stephen Mandel's Lone Pine Capital Portfolio - Q2 2015 Update (Seeking Alpha)

Endo Health Solutions (NASDAQ: ENDP) today announced that its Qualitest subsidiary has reached a definitive agreement to acquire privately held Boca Pharmacal, a specialty generics company, for $225 million in cash.  The transaction is expected to enhance the growth platform and pipeline for Endo's Qualitest business and is consistent with Endo's strategic transformation into a leading specialty healthcare company.

Posted-In: News M&A

 

Related Articles (ENDP)

Get Benzinga's Newsletters